BerGenBio ASA's total assets for Q1 2023 were $8.02B, an increase of 24.07% from the previous quarter. BRRGF total liabilities were $7.12B for the fiscal quarter, a 22.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.